|
Tuberculosis
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The lipolytic protein LipU was conserved in mycobacterium sp. including M. tuberculosis (MTB LipU) and M. leprae (MLP LipU).
|
29557724 |
2019 |
|
Tuberculosis
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The Mycobacterium tuberculosis specific LAMP assay ('MTB LAMP') showed sensitivity and specificity, of 44.7% and 94.4% respectively in a 60 min format, 85.7% and 93.9% respectively in a 90 min format and 91.7%, and 90.9% respectively in a 120 min format.
|
21047534 |
2011 |
|
Tuberculosis
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Correlation of results of polymerase chain reaction for Mycobacterium tuberculosis (MTB PCR) with clinical features and treatment response in tubercular uveitis.
|
28665743 |
2018 |
|
Tuberculosis
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Mycobacteria, including most of all MTB (Mycobacterium tuberculosis), cause pathogenic infections in humans and, during the infectious process, are exposed to a range of environmental insults, including the host's immune response.
|
20522025 |
2010 |
|
Tuberculosis
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Effect of two alternative methods of pooling sputum prior to testing for tuberculosis with genexpert MTB/RIF.
|
31029099 |
2019 |
|
Breast Carcinoma
|
0.090 |
GeneticVariation
|
disease |
BEFREE |
The gene and phenotype frequencies of 5-MT I and 5-MT II were not significantly different in genomic DNA samples from a series of non-Hodgkin's lymphomas and breast cancer cases compared with DNA from normal subjects.
|
9694254 |
1998 |
|
Malignant neoplasm of breast
|
0.080 |
GeneticVariation
|
disease |
BEFREE |
The gene and phenotype frequencies of 5-MT I and 5-MT II were not significantly different in genomic DNA samples from a series of non-Hodgkin's lymphomas and breast cancer cases compared with DNA from normal subjects.
|
9694254 |
1998 |
|
Tuberculosis, extrapulmonary
|
0.070 |
GeneticVariation
|
disease |
BEFREE |
We tested consecutive samples from patients suspected of extrapulmonary tuberculosis with Xpert MTB/Rif, evaluated its sensitivity and specificity against solid and/or liquid culture and CGS.
|
26671654 |
2016 |
|
Glaucoma, Primary Open Angle
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
Myocilin mt1 promoter polymorphism in Turkish patients with primary open angle glaucoma.
|
16280977 |
2005 |
|
Glaucoma, Primary Open Angle
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
There is no association between the MYOC.mt1 promoter polymorphism with the severity of POAG.
|
15354075 |
2004 |
|
Glaucoma, Primary Open Angle
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
The 2 alleles of the MYOC.mt1 promoter polymorphism were equally distributed among patients with POAG and healthy control subjects.
|
12215093 |
2002 |
|
Glaucoma, Primary Open Angle
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
Association between MYOC.mt1 promoter polymorphism and risk of primary open-angle glaucoma: a systematic review and meta-analysis.
|
18591929 |
2008 |
|
Mammary Neoplasms
|
0.030 |
GeneticVariation
|
group |
BEFREE |
Theses studies suggest amplification of the MT1 gene in some breast tumors and an inverse correlation with ERalpha, PR and MT1 protein expression.
|
18979234 |
2009 |
|
Pleural Tuberculosis
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Multivariate analysis identified history of liver disease, MTB culture negativity, having symptoms for <60 days, chest pain, and age>64 years as independent risk factors for PLTB.
|
16466663 |
2006 |
|
Malignant neoplasm of lung
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
We found five polymorphisms in the MT-1 gene region that showed statistically significant associations with lung cancer.
|
25174824 |
2015 |
|
Carcinoma of lung
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
We found five polymorphisms in the MT-1 gene region that showed statistically significant associations with lung cancer.
|
25174824 |
2015 |
|
Primary malignant neoplasm of lung
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
We found five polymorphisms in the MT-1 gene region that showed statistically significant associations with lung cancer.
|
25174824 |
2015 |
|
Glaucoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Testing for the MYOC.mt1 promoter polymorphism appears to be of no value in the evaluation of patients with glaucoma.
|
12215093 |
2002 |
|
Hodgkin Disease
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The gene and phenotype frequencies of 5-MT I and 5-MT II were not significantly different in genomic DNA samples from a series of non-Hodgkin's lymphomas and breast cancer cases compared with DNA from normal subjects.
|
9694254 |
1998 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
In this study we show that mammary tumors from MTB-IGFIR transgenic mice and cell lines derived from these tumors represent a model of human claudin-low breast cancer and murine claudin-low mammary tumors and cell lines express only very low levels of all five members of the miR-200 family.
|
28423599 |
2017 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
The lymphoid component accompanying the tumor was always negative for MT1 receptor.
|
23073719 |
2013 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
The melatonin-MT1 receptor axis modulates tumor growth in PTEN-mutated gliomas.
|
29408377 |
2018 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
In the present study, we report a lncRNA named MT1JP which acts as a tumor suppressor through a posttranscriptional mechanism.
|
26909858 |
2016 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
However, some lncRNAs, such as MEG3, MT1JP, and H19, play a tumor suppressive role.
|
31202519 |
2019 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Therefore, this approach was utilized to classify the mammary tumors that develop in MTB-IGFIR transgenic mice.
|
22020329 |
2012 |